Fundz

Combat Medical raises £2.6 million in Series A funding led by T&J Meyer Family Foundation to advance its HIVEC treatment for bladder cancer.

PRIVATEMar 12, 2026

Amount Raised

£2.6 Million

Round Type

Series A

BiotechnologyHealth CareMedicalMedical DeviceTherapeutics

Investors

Varia VenturesNw Angel FundT&J Meyer Family Foundation

Description

Combat Medical has successfully completed the first close of its Series A financing, raising £2.6 million. The funding will propel the pivotal FDA registration trial for its innovative HIVEC treatment targeting BCG unresponsive bladder cancer. This financing round is led by T&J Meyer Family Foundation along with Varia Ventures and other investors. Combat aims to scale operations and expand its clinical programs as they work towards FDA approval.

Quick answer

Combat Medical raised £2.6 Million in a Series A round, dated March 12, 2026. Investors: Varia Ventures, Nw Angel Fund and T&J Meyer Family Foundation.

How much did Combat Medical raise?
Combat Medical raised £2.6 Million in a Series A round on March 12, 2026.
Who invested in Combat Medical?
Varia Ventures, Nw Angel Fund and T&J Meyer Family Foundation are named as investors in this round.
What does Combat Medical do?
Combat Medical is a medical device company focused on optimizing the delivery and efficacy of cancer therapeutics.
Who are the decision-makers at Combat Medical?
Fundz holds 1 contact at Combat Medical, including the Sales & Marketing Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Combat Medical that raised within 45 days of this round, from Fundz verified event records.

  • Sonire Therapeutics raised $18M (Series A) on March 31, 2026.
  • TransCode Therapeutics raised $20M (Funding Round) on April 7, 2026.
  • PanTera raised $4M on March 31, 2026.
  • Sub-Q Bionics raised $1.5M (Pre-Seed) on March 31, 2026.
  • TippingPoint Biosciences raised $4.5M (Seed) on March 31, 2026.
  • IceCure Medical raised $4M on March 26, 2026.

Who to call at Combat Medical, and when

A new round usually means Combat Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Combat Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Combat Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Combat Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Combat Medical

About

Combat Medical is a medical device company focused on optimizing the delivery and efficacy of cancer therapeutics. The company specializes in hyperthermic intravesical chemotherapy treatments for BCG unresponsive bladder cancer. With over 350 installed systems and more than 100,000 treatments completed, Combat Medical provides a bladder-sparing alternative to radical cystectomy. Their patented HIVEC treatment aims to gain FDA registration and improve patient care standards.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Combat Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsGuy R., Sales & Marketing Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Combat Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Combat Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.